Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies

Blood Adv. 2021 Nov 23;5(22):4630-4633. doi: 10.1182/bloodadvances.2021004190.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hematologic Neoplasms* / epidemiology
  • Hematologic Neoplasms* / therapy
  • Humans
  • Quality of Life*